What is august bioservices?
August Bioservices is a specialized firm comprising seasoned life science professionals dedicated to providing comprehensive research, pharmaceutical development, and manufacturing services. Catering to clients within the pharmaceutical and biotechnology industries, the company emphasizes its commitment to integrity, persistence, and ingenuity in overcoming challenges to meet client objectives. Founded in 2017 and headquartered in Nashville, Tennessee, August Bioservices positions itself as a reliable partner for complex scientific endeavors.
How much funding has august bioservices raised?
august bioservices has raised a total of $88.6M across 2 funding rounds:
Series A
$23.6M
Series B
$65M
Series A (2021): $23.6M with participation from Polaris Partners and Oak HC/FT
Series B (2022): $65M led by Oak HC/FT and Polaris Partners
Key Investors in august bioservices
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund specializing in Healthcare Information & Services and Financial Services Technology. With substantial assets under management, they focus on driving transformation through strategic counsel and network access.
Polaris Partners
Polaris Partners is a venture capital firm that backs transformational companies in the biotech and healthcare sectors, offering coaching, advice, and resources for growth.
Polaris Partners
Polaris Partners Advisory is preparing to launch, aiming to provide advisory services within the industry, though specific details are pending.
What's next for august bioservices?
The recent major strategic investment in August Bioservices signals a pivotal phase for the company, likely enabling expansion of its service offerings, enhancement of its research and development capabilities, and potentially scaling its manufacturing operations. This significant capital infusion, following earlier rounds of financing, suggests a strategic focus on accelerating growth and solidifying its market position. Investors such as Oak HC/FT and Polaris Partners, known for their deep expertise in healthcare and biotechnology, are likely providing not only financial backing but also strategic guidance to help August Bioservices navigate the evolving landscape of drug discovery and development.
See full august bioservices company page